Apr 20 2011
Rothman Healthcare Corporation announced a strategic partnership today with The Methodist Hospital System in Houston. Methodist will use the Rothman Index to improve patient care.
“The Methodist Hospital, ranked among the nation's best hospitals, is an ideal partner to collaborate with in groundbreaking research.”
Since 2005, Rothman Healthcare has developed the Rothman Index to improve quality outcomes and bridge gaps in the continuity of care. The Rothman Index captures data found in a hospital's electronic health record to display progression of a patient's health over time. The Rothman Index generates a regularly updated health score synthesizing routine vital signs, nursing assessments, and lab results, for display in a user-friendly graphical format, summarizing thousands of pages of patient data at a glance. The Rothman Index makes it easier to track patient progress and detect subtle declines in health visually. Rapid Response Teams, physicians and nurses now have the ability to see multiple patient graphs simultaneously for earlier interventions and a summarized understanding of a whole unit, providing patients the extraordinary care they need as effectively and as soon as possible.
The Methodist Hospital has long been renowned for being at the forefront of innovation for medical care and will be among the first hospitals to adopt Rothman Healthcare's cutting edge technology to improve outcomes. The Rothman Index allows for greater clinical surveillance of patients and earlier interventions. Rothman Healthcare will conduct studies on how best to use the visualized Rothman Index data with Maureen Disbot, MS, RN, CCRN, vice president of quality operations and Stephen L. Jones, MD, MHIS, chief clinical informatics officer -- Department of Surgery.
"We are honored to be working with a world renowned institution such as The Methodist Hospital in Houston," remarks Rothman Healthcare's CEO Richard Sommer. "The Methodist Hospital, ranked among the nation's best hospitals, is an ideal partner to collaborate with in groundbreaking research."
Source:
Rothman Healthcare Corporation